Enqi Qiao Selected Research

Neoplasms (Cancer)

11/2022	Fucoidan-based dual-targeting mesoporous polydopamine for enhanced MRI-guided chemo-photothermal therapy of HCC via P-selectin-mediated drug delivery.
5/2022	DNA-Functionalized Liposomes In Vivo Fusion for NIR-II/MRI Guided Pretargeted Ferroptosis Therapy of Metastatic Breast Cancer.
4/2022	Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization.
1/2022	HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma.
3/2021	Sialic acid-engineered mesoporous polydopamine dual loaded with ferritin gene and SPIO for achieving endogenous and exogenous synergistic T2-weighted magnetic resonance imaging of HCC.
1/2019	Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57KIP2 and involving in p-p38 MAPK and NF-κB pathways.
4/2013	Expression of the PXR gene in various types of cancer and drug resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enqi Qiao Research Topics

Disease

7	Neoplasms (Cancer) 11/2022 - 04/2013
5	Breast Neoplasms (Breast Cancer) 06/2022 - 04/2017
3	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2022
2	Glioma (Gliomas) 07/2015 - 01/2015
1	Hypoxia (Hypoxemia) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Pathologic Complete Response 01/2019
1	Lymphatic Metastasis 01/2019
1	Lymphedema (Milroy Disease) 01/2019
1	Carcinoma (Carcinomatosis) 04/2017

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 05/2022
2	Liposomes (Liposome)IBA 06/2022 - 05/2022
2	ferric oxide (iron oxide)IBA 05/2022 - 03/2021
2	Proteins (Proteins, Gene)FDA Link 04/2017 - 01/2015
1	fucoidanIBA 11/2022
1	P-SelectinIBA 11/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2022
1	Peptides (Polypeptides)IBA 05/2022
1	IronIBA 05/2022
1	Glucose OxidaseIBA 05/2022
1	2,6-dichloro-4-nitrophenolIBA 05/2022
1	Contrast MediaIBA 05/2022
1	Single-Stranded DNA (DNA, Single Stranded)IBA 05/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	piperlongumineIBA 01/2022
1	Ferritins (Ferritin)IBA 03/2021
1	3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA 03/2021
1	Messenger RNA (mRNA)IBA 05/2020
1	Long Noncoding RNAIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 04/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 07/2015
1	CELF1 ProteinIBA 01/2015
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2015
1	EnzymesIBA 04/2013
1	XenobioticsIBA 04/2013

Therapy/Procedure

5	Therapeutics 06/2022 - 01/2019
1	Precision Medicine 11/2022
1	Photothermal Therapy 11/2022
1	Induced Hyperthermia (Thermotherapy) 04/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Microspheres (Microsphere) 01/2022
1	Radiotherapy 05/2020
1	Lymph Node Excision (Lymph Node Dissection) 05/2020
1	Neoadjuvant Therapy 01/2019